Global Monoclonal Antibody Development Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Monoclonal Antibody Development Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Monoclonal antibody development services are antibody preparation services tailored to the specific needs of clients. The goal is to generate highly specific and affinity matured monoclonal antibodies for the detection and analysis of specific target molecules. These services are typically provided by specialized antibody development companies, where clients can provide their target antigen or receive guidance to select the most appropriate antigen. The service usually includes immunization of animals with the antigen, hybridoma fusion and screening for monoclonal antibodies, and validation and purification of the monoclonal antibodies. These monoclonal antibodies can be used for various applications, such as immunohistochemistry, immunoblotting, immunoprecipitation, flow cytometry, ELISA, and more.
Monoclonal Antibody Development Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Monoclonal Antibody Development Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biopharmaceuticals and Medical Diagnosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Monoclonal Antibody Development Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Monoclonal Antibody Development Services key companies include Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, Bhat Biotech, Synaptic Systems, Covalab and CePower, etc. Eurogentec, ProSci, Syd Labs are top 3 players and held % share in total in 2022.
Monoclonal Antibody Development Services can be divided into Small-scale, Medium-sclae and Large-scale,, etc. Small-scale is the mainstream product in the market, accounting for % share globally in 2022.
Monoclonal Antibody Development Services is widely used in various fields, such as Biopharmaceuticals, Medical Diagnosis, Agricultural and Medical Treatment, etc. Biopharmaceuticals provides greatest supports to the Monoclonal Antibody Development Services industry development. In 2022, global % share of Monoclonal Antibody Development Services went into Biopharmaceuticals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Monoclonal Antibody Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Eurogentec
ProSci
Syd Labs
Promab
Antibodies Inc
Bhat Biotech
Synaptic Systems
Covalab
CePower
Lampire Biological Laboratories
Leinco Technologies
Medimabs
Davids Bioengineering
Scantibodies
Abwiz Bio
Thermo Fisher Scientific
Segment by Type
Small-scale
Medium-sclae
Large-scale
Biopharmaceuticals
Medical Diagnosis
Agricultural
Medical Treatment
Environmental monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Monoclonal Antibody Development Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Monoclonal Antibody Development Services introduction, etc. Monoclonal Antibody Development Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Monoclonal Antibody Development Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Monoclonal Antibody Development Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Monoclonal Antibody Development Services market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biopharmaceuticals and Medical Diagnosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Monoclonal Antibody Development Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Monoclonal Antibody Development Services key companies include Eurogentec, ProSci, Syd Labs, Promab, Antibodies Inc, Bhat Biotech, Synaptic Systems, Covalab and CePower, etc. Eurogentec, ProSci, Syd Labs are top 3 players and held % share in total in 2022.
Monoclonal Antibody Development Services can be divided into Small-scale, Medium-sclae and Large-scale,, etc. Small-scale is the mainstream product in the market, accounting for % share globally in 2022.
Monoclonal Antibody Development Services is widely used in various fields, such as Biopharmaceuticals, Medical Diagnosis, Agricultural and Medical Treatment, etc. Biopharmaceuticals provides greatest supports to the Monoclonal Antibody Development Services industry development. In 2022, global % share of Monoclonal Antibody Development Services went into Biopharmaceuticals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Monoclonal Antibody Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Eurogentec
ProSci
Syd Labs
Promab
Antibodies Inc
Bhat Biotech
Synaptic Systems
Covalab
CePower
Lampire Biological Laboratories
Leinco Technologies
Medimabs
Davids Bioengineering
Scantibodies
Abwiz Bio
Thermo Fisher Scientific
Segment by Type
Small-scale
Medium-sclae
Large-scale
Segment by Application
Biopharmaceuticals
Medical Diagnosis
Agricultural
Medical Treatment
Environmental monitoring
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Monoclonal Antibody Development Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Monoclonal Antibody Development Services introduction, etc. Monoclonal Antibody Development Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Monoclonal Antibody Development Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices